WebJan 10, 2024 · Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the treatment of patients with cardiac arrhythmias (irregular heartbeats) such as atrial fibrillation (AF). WebDec 20, 2024 · First patient treated in US IDE SPHERE PerAF at @MountSinaiNYC by Drs. @VivekReddyMD @jskoruth @billwhangep and others. Affera also announces $75M series C with Bain Capital Life Sciences.
Affera Announces First Patient Treated in SPHERE Per-AF IDE …
WebThe SPHERE PerAF trial uses pulsed field ablation to normalize an irregular heartbeat and is the first randomized catheter ablation IDE trial to treat persistent atrial fibrillation. The … WebDec 20, 2024 · NEWTON, Mass., Dec. 20, 2024 /PRNewswire/ -- Affera Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, … the ship busselton
Medtronic to Acquire Affera - Jan 10, 2024
WebCongratulations to the Sentara team members who successfully completed our first patient procedure in the recently approved SPHERE PerAF Trial! This clinical trial will evaluate the safety and ... WebJan 10, 2024 · In December 2024, Affera announced the commencement of the recently approved SPHERE PerAF Trial, a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) pivotal randomised trial, to evaluate the safety and effectiveness of the Affera system for the treatment of persistent AF. WebFirst Patient Treated in SPHERE PerAF Trial December 21st, 2024 Professional Memberships American College of Cardiology - ACC Member Hospital Affiliations Morristown Medical CenterMorristown, New Jersey Viewing the full profile is available to verified healthcare professionals only. Find your profile and take control of your online … my skin laser clinic